Ergoteles’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-17,733
Closed -$3.59M 1675
2023
Q1
$3.59M Sell
17,733
-5,140
-22% -$824K 0.14% 122
2022
Q4
$2.94M Buy
22,873
+13,591
+146% +$1.75M 0.11% 191
2022
Q3
$1.27M Buy
+9,282
New +$1.51M 0.04% 403
2022
Q2
Sell
-4,830
Closed -$696K 2100
2022
Q1
$696K Buy
+4,830
New +$653K 0.03% 551
2021
Q2
Sell
-34,771
Closed -$4.83M 1739
2021
Q1
$4.83M Buy
+34,771
New +$5.6M 0.15% 169

Other funds holding SGEN

Ergoteles's SGEN Position: Q2 2023 in Review

Ergoteles sold out of Seagen Inc. Common Stock (SGEN) in Q2 2023, closing a stake of 17,733 shares — an estimated $3.59M sold.

Ergoteles first reported a position in SGEN in Q1 2021 and held it in 5 quarters. The position peaked at $4.83M in Q1 2021. 594 funds tracked by Wall St. Rank hold SGEN as of Q2 2023.

  • Ergoteles reported no remaining Seagen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 17,733 Seagen Inc. Common Stock shares in Q2 2023, an estimated $3.59M.
  • Ergoteles first reported a position in Seagen Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Ergoteles's Seagen Inc. Common Stock position peaked at $4.83M in Q1 2021.
  • 594 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.